CHARLESTON, S.C.--(BUSINESS WIRE)--Zestra Laboratories, Inc., global innovator in clinically proven intimacy products for women’s sexual health, announces the election of four new members to its board of directors, bringing the current number of board members to five. Its flagship product, Zestra® is available at more than 41,000 drugstore and retail outlets in the United States. It is the only women’s topical intimacy product that is clinically proven to increase female sexual arousal, pleasure, desire/libido and satisfying sexual experiences for women; everything else available for women are simply lubricants. To date, there are still no FDA-approved prescription drug treatments for any form of female sexual dysfunction (FSD).
